Arcus Biosciences, Inc.

NYSE:RCUS

10.59 (USD) • At close August 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019201820172016
Revenue 25811711238378158.3531.4130
Cost of Revenue 000000001.314
Gross Profit 25811711238378158.3531.413-1.314
Gross Profit Ratio 111111110
Reseach & Development Expenses 44834028825715978.48149.64647.21814.247
General & Administrative Expenses 120117104724325.22813.5667.6363.935
Selling & Marketing Expenses 000000000
SG&A 120117104724325.22813.5667.6363.935
Other Expenses 2000000000
Operating Expenses 588457392329202103.70963.21254.85418.182
Operating Income -330-340-28054-124-88.709-54.859-53.441-18.182
Operating Income Ratio -1.279-2.906-2.50.141-1.59-5.914-6.568-37.8210
Total Other Income Expenses Net 473914113.9995.2650.3590.212
Income Before Tax -283-301-26655-123-84.71-49.594-53.082-17.97
Income Before Tax Ratio -1.097-2.573-2.3750.144-1.577-5.647-5.937-37.5670
Income Tax Expense 161200000
Net Income -283-307-26753-123-84.71-49.594-53.082-17.97
Net Income Ratio -1.097-2.624-2.3840.138-1.577-5.647-5.937-37.5670
EPS -3.14-4.15-3.710.76-2.13-1.73-1.43-2.16-0.73
EPS Diluted -3.14-4.15-3.710.71-2.13-1.73-1.43-2.16-0.73
EBITDA -269-291-25859-120-81.132-51.195-50.829-16.868
EBITDA Ratio -1.043-2.487-2.3040.154-1.538-5.409-6.129-35.9720